Capability Insight Brief
How Global Organizations Define Scientific Capability
A CapabilityPrint™ comparison of scientific and research roles across pharmaceuticals, healthcare, food, and consumer products.
EXECUTIVE SUMMARY
Scientific work is often viewed as highly specialized, with capability requirements shaped primarily by discipline-specific expertise.
CapabilityPrint™ analysis suggests a broader picture.
Across research roles in pharmaceuticals, healthcare, food science, biomaterials, and consumer products, organizations consistently sought capabilities extending well beyond technical knowledge.
Modern scientists are expected to interpret evidence, communicate findings, manage information, collaborate across disciplines, and support organizational decision-making.
The findings suggest that scientific capability is becoming increasingly multidisciplinary.
RESEARCH QUESTION
How consistently do global organizations define scientific capability across industries, and what capabilities distinguish modern scientific work?
EVIDENCE BASE
CapabilityPrint™ assessments analyzed: 3
Industries represented:
Pharmaceuticals
Healthcare
Consumer Products
Organization types represented:
Global pharmaceutical companies
Consumer goods manufacturers
Food science organizations
THE ROLES
Different organizations. Different industries. Same job family. See how capability demand varies.
KEY FINDINGS
Scientific work is increasingly multidisciplinary.
Every organization expects scientists to combine technical expertise with communication, collaboration, critical thinking, and structured decision-making.
Scientific excellence alone was insufficient.
Evidence is the foundation of scientific capability.
Across every CapabilityPrint™, scientists were expected to evaluate information, validate findings, and support decisions using reliable evidence.
Evidence quality consistently emerged as a defining capability.
Collaboration has become a core scientific capability.
Modern research rarely occurs in isolation.
Scientists increasingly work across engineering, manufacturing, commercial, regulatory, and operational teams.
CapabilityPrint™ assessments consistently highlighted the importance of communicating complex concepts to diverse audiences.
Innovation depends on structured decision-making.
Scientific roles were expected not only to generate knowledge but also to prioritize opportunities, balance risks, evaluate alternatives, and recommend practical actions.
Decision quality emerged as a recurring capability across every organization.
WHAT THIS MEANS FOR ORGANIZATIONS
Organizations should ask:
- Are scientific capability frameworks overly focused on technical expertise?
- How effectively do scientists develop communication and decision-making capabilities?
- Do capability models reflect multidisciplinary research environments?
- How should AI augment scientific work while preserving critical judgment?
- Which capabilities distinguish scientific leadership from scientific expertise?
RELATED KNOWLEDGE
Workforce Capability
Capability Intelligence
METHODOLOGY
Capability Insight Briefs synthesize evidence from multiple CapabilityPrint™ assessments generated using the CapabilityPrint™ methodology. As additional scientific CapabilityPrint™ assessments are published, this brief will be updated to incorporate new evidence and strengthen confidence in the findings.
This Capability Insight compares CapabilityPrint™ assessments generated from publicly available scientific and research roles including:
Pfizer - Senior Scientist, Antibody Engineering & Discovery
Johnson & Johnson - Senior R&D Scientist, Biomaterials
Unilever - UFS Scientist, Foods CTI
Although these organizations operate in different industries, each role contributes to research, product development, innovation, or scientific knowledge transfer.
Each CapabilityPrint™ was analyzed using the CapabilityPrint™ methodology.